// App-Quantinova.ai

120 : The right choice? Secukinumab in co-existing axial disease and multiple sclerosis

Researchers

Presenter

  • Arti Mahto

Principal Investigators

  • Ghazal Ansari

  • Asim Khan

  • Rebecca Adshead

  • Hasan Tahir

Medical Centers

  • Rheumatology Research, Whipps Cross Hospital, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Ankylosing spondylitis

  • Multiple Sclerosis

  • Sacroiliitis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved